Revolutionizing Herniated Disc Surgery | Barricaid
Intrinsic Therapeutics develops implantable devices to prevent recurrent disc herniation following lumbar discectomy surgery. Its flagship product, Barricaid, is an FDA Pre-Market Approved annular closure device that uses a flexible polymer mesh and titanium bone anchor to seal large annular defects. The device demonstrated superior outcomes to discectomy alone in a multicenter Level I randomized controlled trial, reducing reherniation and reoperation rates.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2019
May 2017
May 2017
Sep 2014
Nov 2012
Feb 2010
Create a free account to see which investors have funded this company.
Create Free Account
operates in the healthcare industry focusing on biotechnology business
Healthcare AI platform that converts patient-clinician conversations into structured clinical not...
OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
